Veronika Vojáčková

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Acute Myeloid Leukemia

Endoplasmic Reticulum Stress

Cell Cycle Arrest

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Journal of medicinal chemistry

Archiv der Pharmazie

This page only lists publications with an associated author ORCID identifier.

Publications

Gabrielė Varvuolytė, Eva Řezníčková, Aurimas Bieliauskas, Neringa Kleizienė, Veronika Vojáčková, Alena Opichalová, Asta Žukauskait, Vladimir Kryštof, Algirdas Šačkus
Synthesis and photodynamic activity of new 5-[(E)-2-(3-alkoxy-1-phenyl-1H-pyrazol-4-yl)ethenyl]-2-phenyl-3H-indoles. Archiv der Pharmazie (2024)
Petra Břehová, Eva Řezníčková, Kryštof Škach, Radek Jorda, Milan Dejmek, Veronika Vojáčková, Michal Šála, Markéta Kovalová, Martin Dračínský, Alexandra Dolníková, Timotej Strmeň, Monika Kinnertová, Karel Chalupský, Alexandra Dvořáková, Tomáš Gucký, Helena Mertlíková Kaiserová, Pavel Klener, Radim Nencka, Vladimir Kryštof
Inhibition of FLT3-ITD Kinase in Acute Myeloid Leukemia by New Imidazo[1,2- b ]pyridazine Derivatives Identified by Scaffold Hopping. Journal of medicinal chemistry (2023)
Tânia Moreira, Domingos M Manuel, Joana Rosa, Rafael Santana Nunes, Veronika Vojáčková, Radek Jorda, Maria Conceiçao Oliveira, Nuno Manuel Xavier
Synthesis and Antiproliferative Evaluation of d-Glucuronamide-Based Nucleosides and (Triazolyl)methyl Amide-Linked Pseudodisaccharide Nucleosides. ChemMedChem (2023)
Andreia Fortuna, Rita G Pereira, Paulo J Costa, Radek Jorda, Veronika Vojáčková, Gabriel Gonzalez, Niels V Heise, Rene Csuk, Maria Conceiçao Oliveira, Nuno Manuel Xavier
Synthesis and Exploitation of the Biological Profile of Novel Guanidino Xylofuranose Derivatives. ChemMedChem 17 (14) (2022)
Radek Jorda, Libor Havlíček, Miroslav Peřina, Veronika Vojáčková, Tomáš Pospíšil, Stefan Djukic, Jana Škerlová, Jiri Gruz, Nicol Renešová, Pavel Klener, Pavlína Řezáčová, Miroslav Strnad, Vladimir Kryštof
3,5,7-Substituted Pyrazolo[4,3- d ]Pyrimidine Inhibitors of Cyclin-Dependent Kinases and Cyclin K Degraders. Journal of medicinal chemistry 65 (13) (2022)